Iofina PLC has reported a historic output of 743.2 metric tonnes of crystalline iodine in 2025, a 17.2% increase over the previous year and the highest annual total in the company’s history. This performance reflects successful optimization of its proprietary WET® iodine extraction technology at multiple US oilfield brine sites, including expanded operations in Oklahoma and Wyoming. The accelerated production schedule has positioned the company to capitalize on robust global demand, particularly from pharmaceutical and electronics manufacturers.

Based on current iodine price levels, which have remained elevated due to constrained global supply, Iofina now expects both revenues and profits for its 2025 fiscal year to exceed prior market forecasts. Management has guided for full-year revenue growth of at least 25% year-on-year, driven by record iodine sales volumes and sustained pricing above $30 per kilogram. Operating margins are projected to improve by 200 basis points, reflecting greater scale and ongoing cost efficiencies in well servicing and brine management.

Following the production announcement, Iofina’s American Depositary Receipt shares climbed 6%, trading at 27.6p, as investors recalibrated earnings estimates and consensus revenue forecasts were revised upward by leading brokerages. Analysts have highlighted the company’s strengthened balance sheet, with net cash expected to exceed £8 million by year-end, and the potential for further margin expansion through additional plant starts scheduled in H2 2025. Specialist commodity funds and long-only equities managers have notably increased their weightings, underscoring renewed confidence in Iofina’s growth trajectory.